Skip to main content
The Lancet

The Lancet

Newspaper | United Kingdom | Centre

Engagement Insights

0.41 score
14
Discussions
6
Participants
14
Total Votes
103
Articles

Discussions from The Lancet

Healthcare

How can Uganda and DR Congo work together to improve health responses during crises like Ebola?

The declaration on July 28, 2026, that the Bundibugyo virus outbreak in Uganda had ended marks a crucial milestone in outbreak control.1 WHO considers an Ebola outbreak resolved 42 consecutive days after the second negative PCR test result of the last patient, or their safe burial.2 Although this threshold effectively captures the interruption of transmission, it remains strictly epidemiological. In reality, the true end of an epidemic is not a singular event but a complex clinical, health system, and social transition that extends far beyond the final detected case

Uganda
Join Discussion
Healthcare

How can we better address the connection between HIV and sepsis in global health policies?

We read with interest the Seminar by Mervyn Singer and colleagues,1 which highlights advances and ongoing challenges in sepsis pathobiology and therapeutics. The authors discuss immunosuppression as a key modifier of sepsis risk, clinical presentation, and outcomes, particularly among individuals with organ transplantation, autoimmune disease, and malignancy.1 However, despite being a major determinant of sepsis epidemiology and outcomes in high-burden settings, HIV co-infection is left unmentioned

Global
Join Discussion
Healthcare

How might the discovery of plasma biomarkers for Alzheimer's in middle-aged people affect health policies and community support programs?

Alzheimer's disease has a long preclinical phase in which neuropathological changes, such as amyloid β (Aβ) and tau pathology, accumulate over many years.1 This preclinical phase provides an opportunity for earlier disease detection and interventions to prevent or delay dementia. Emerging blood-based biomarkers provide a minimally invasive approach to assess Alzheimer's disease-related pathology and show promising diagnostic and prognostic value in symptomatic individuals.2 However, performance of these biomarkers in cognitively unimpaired, middle-aged populations remains unclear

Global
Join Discussion
Society

How can we improve our humanitarian system to better address inequalities and support mutual aid efforts?

The humanitarian system presents itself as a beacon of hope amid humanitarian crises, a vision that drew many of us into the field of humanitarian work. Yet once inside, the ideal unravels. Rooted in colonial histories and perpetuated by enduring global power asymmetries and the neoliberal logic of the aid sector, the humanitarian system frequently reinforces the very inequities it purports to resolve.1 These inequities manifest through policies and frameworks, as well as via interpersonal and cultural practices that, implicitly or explicitly, marginalise the most vulnerable

Global
Join Discussion
Healthcare

How should we change our approach to global health to make it better for everyone?

The Offline piece1 by Richard Horton is right that global health is on the brink: funding is collapsing, political volatility persists unabated, and powerful actors are renegotiating international engagement. But the answer is not simply a new narrative organised around climate, pandemics, conflict, migration, demography, or digital transformation. What global health requires is structural reorientation

Global
Join Discussion
Healthcare

How can we improve treatment options for patients with squamous NSCLC based on recent research findings?

We read with interest the results of the HARMONi-6 trial by Zhiwei Chen and colleagues,1 which showed that ivonescimab plus chemotherapy improved progression-free survival versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (NSCLC). However, PD-L1-based subgroup results reveal a critical stratification signal. In patients with PD-L1 tumour proportion score (TPS) of under 50%, dual blockade achieved marked benefit (hazard ratio [HR] 0·63; 95% CI 0·41–0·98), whereas in patients with PD-L1 TPS of 50% or over, the improvement was numerical but not significant (HR 0·71; 0·37–1·33)

Global
Join Discussion
Healthcare

How can India create a health system that works for all citizens?

The Lancet Commission on a Citizen-Centred Health System for India presents a timely and comprehensive assessment of India's health system.1 Although noting India's progress in reducing infant and maternal mortality and increasing life expectancy, the report also highlights persistent gaps in health-care delivery, and identifies that the main challenges are fragmented governance, poorly coordinated delivery, and a system organised around facilities rather than patients. The Commission's equal emphasis on equity and efficiency is also crucial

India
Join Discussion